ROCKET ONE INC (RKTO)
NASDAQHealth CareSoftware - InfrastructureSnapshot 2026-10-30
NASDAQHealth CareSoftware - InfrastructureSnapshot 2026-10-30
Research Workspace
Put RKTO beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Systems Software: fringe margins under pressure (2q confirmed)
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
The reason to own it still holds.
View ThesisManagement screens weak on capital allocation, earnings delivery, market reaction to earnings.
View ManagementThis stock is highly volatile — it swings about 2% on a typical day and fell roughly 78% in its worst 12-month stretch.
View RiskRKTO’s bet is radiation-tolerant spintronic memory, backed by a research deal. Its recent revenue growth and latest result cannot be verified from this desk. The desk has no valuation multiple or peer comparison for RKTO. It also has no priced-in expectations, so the price argument remains unknown. Our model puts the next-quarter miss probability at 62%. RKTO is unprofitable, and management has been unsteady. The thesis remains intact, but confidence is low. This read is provisional.
Trailing returns as of 2026-10-30. RKTO is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 1 analyst currently covering RKTO (as of Jun 2026).
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
Continue this research
Compare RKTO with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| RKTO Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 0 valuation methods, at three horizons. As of 2026-11-01. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Systems Software — fair value, gap to price, and forward P/E.
Compare the value case
Put RKTO next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Advances: Develop radiation-tolerant spintronic memory technology
Research deal supports development of radiation-tolerant spintronic memory.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-30. EPS is implied from price ÷ P/E. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
TTM earnings are negative. P/E-based methods drop out and the estimate leans on sales- and cash-flow-based methods. A data condition, not a forward call.

Licensing NASA technology is a significant strategic advancement.

Agreement with NASA enhances technological capabilities significantly.

Collaboration with NASA is a major boost for innovation.

Partnership with NASA solidifies competitive positioning.

Strategic partnership expands AI capabilities in key sectors.

Integration of SpaceXAI API enhances technological offerings.

Stock surge indicates strong market confidence in growth.